• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Clinical pharmacokinetics of cyclophosphamide.

作者信息

Grochow L B, Colvin M

出版信息

Clin Pharmacokinet. 1979 Sep-Oct;4(5):380-94. doi: 10.2165/00003088-197904050-00004.

DOI:10.2165/00003088-197904050-00004
PMID:389529
Abstract
摘要

相似文献

1
Clinical pharmacokinetics of cyclophosphamide.环磷酰胺的临床药代动力学
Clin Pharmacokinet. 1979 Sep-Oct;4(5):380-94. doi: 10.2165/00003088-197904050-00004.
2
[The pharmacokinetics and metabolism of flunitrazepam].[氟硝西泮的药代动力学与代谢]
Klin Anasthesiol Intensivther. 1978(17):8-24.
3
Basic pharmacokinetics.基础药代动力学
Ther Drug Monit. 1986;8(1):47-58. doi: 10.1097/00007691-198603000-00010.
4
Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration.静脉注射和口服后环磷酰胺在人体中的药代动力学及烷化活性
Br J Clin Pharmacol. 1979 Sep;8(3):209-17. doi: 10.1111/j.1365-2125.1979.tb01004.x.
5
[Absorption of high doses of cyclophosphamide given orally].[口服高剂量环磷酰胺的吸收情况]
Pharmazie. 1983 Jun;38(6):425-6.
6
Clinical pharmacokinetics of valproic acid.丙戊酸的临床药代动力学
Clin Pharmacokinet. 1980 Jan-Feb;5(1):67-83. doi: 10.2165/00003088-198005010-00002.
7
Clinical pharmacokinetics of oral cephalosporins.
Antibiot Chemother (1971). 1995;47:34-71. doi: 10.1159/000430073.
8
Clinical application of the pharmacokinetics of procaine amide.
Cardiovasc Clin. 1974;6(2):63-75.
9
Sensible prescribing. II--What happens to all the pills they swallow?合理用药。II——他们吞下的所有药片都怎么样了？
Practitioner. 1975 Feb;214(1280):274-81.
10
Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man.
Pharmacol Ther. 1985;29(2):157-204. doi: 10.1016/0163-7258(85)90028-2.

引用本文的文献

1
Cyclophosphamide-induced multiple organ dysfunctions: unravelling of dose dependent toxic impact on biochemistry and histology.环磷酰胺诱导的多器官功能障碍：剂量依赖性毒性对生物化学和组织学影响的解析
Toxicol Res (Camb). 2024 Dec 17;13(6):tfae201. doi: 10.1093/toxres/tfae201. eCollection 2024 Dec.
2
Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case report.口服环磷酰胺诱发抗中性粒细胞胞浆抗体相关性血管炎患者发生后部可逆性脑病综合征：一例报告
World J Clin Cases. 2021 Jul 26;9(21):6130-6137. doi: 10.12998/wjcc.v9.i21.6130.
3
Effect of Chemotherapeutics and Tocopherols on MCF-7 Breast Adenocarcinoma and KGN Ovarian Carcinoma Cell Lines .

本文引用的文献

1
[ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO].[关于环磷酰胺在体内和体外的活化作用]
Arzneimittelforschung. 1963 Dec;13:1021-31.
2
Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses.环磷酰胺对晚期肺癌的作用及大剂量间歇性静脉注射的血液学毒性
Can Med Assoc J. 1968 Mar 16;98(11):532-8.
3
Metabolism of cyclophosphamide-C14 by various marine species.不同海洋物种对环磷酰胺-C14的代谢
化疗药物和生育酚对 MCF-7 乳腺癌腺癌细胞系和 KGN 卵巢癌细胞系的影响。
Biomed Res Int. 2019 Jan 15;2019:6146972. doi: 10.1155/2019/6146972. eCollection 2019.
4
Ginsenoside Rg1 improves bone marrow haematopoietic activity via extramedullary haematopoiesis of the spleen.人参皂苷Rg1通过脾脏的髓外造血改善骨髓造血活性。
J Cell Mol Med. 2015 Nov;19(11):2575-86. doi: 10.1111/jcmm.12643. Epub 2015 Jul 8.
5
Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.白塞病眼部症状管理的当前趋势
Clin Ophthalmol. 2009;3:567-79. doi: 10.2147/opth.s4445. Epub 2009 Oct 19.
6
Clinical pharmacokinetics of cyclophosphamide.环磷酰胺的临床药代动力学
Clin Pharmacokinet. 2005;44(11):1135-64. doi: 10.2165/00003088-200544110-00003.
7
Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.肌酐清除率对老年乳腺癌辅助化疗患者毒性模式的影响。
Drugs Aging. 2005;22(9):785-91. doi: 10.2165/00002512-200522090-00007.
8
Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much?环磷酰胺治疗系统性坏死性血管炎和狼疮性肾炎。疗程多久？剂量多少？
Pediatr Nephrol. 2004 Sep;19(9):949-55. doi: 10.1007/s00467-004-1553-6. Epub 2004 Jul 15.
9
Effect of haemodialysis on the pharmacokinetics of antineoplastic drugs.血液透析对抗肿瘤药物药代动力学的影响。
Clin Pharmacokinet. 2004;43(8):515-27. doi: 10.2165/00003088-200443080-00002.
10
Optimisation of cyclophosphamide therapy in systemic vasculitis.系统性血管炎中环磷酰胺治疗的优化
Clin Pharmacokinet. 1998 Jan;34(1):79-90. doi: 10.2165/00003088-199834010-00004.
Arch Int Pharmacodyn Ther. 1969 Jan;177(1):60-70.
4
Pharmacokinetics of cyclophosphamide in man.环磷酰胺在人体中的药代动力学。
Br J Pharmacol. 1971 Nov;43(3):677-80. doi: 10.1111/j.1476-5381.1971.tb07199.x.
5
Urinary metabolites of the antitumor agent cyclophosphamide.抗肿瘤药物环磷酰胺的尿液代谢产物。
Mol Pharmacol. 1971 Sep;7(5):519-29.
6
Activation of cyclophosphamide in man and animals.
Cancer. 1971 Jun;27(6):1512-29. doi: 10.1002/1097-0142(197106)27:6<1512::aid-cncr2820270636>3.0.co;2-q.
7
Therapeutic efficacy of cyclophosphamide as a function of its metabolism.环磷酰胺的治疗效果与其代谢的关系。
Cancer Res. 1972 Mar;32(3):535-42.
8
Metabolism of cyclophosphamide by sheep.绵羊对环磷酰胺的代谢
J Agric Food Chem. 1972 Mar-Apr;20(2):384-8. doi: 10.1021/jf60180a054.
9
The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivo.苯巴比妥或2-二乙氨基乙基-2,2-二苯基戊酸酯对环磷酰胺体内活化的影响。
J Pharmacol Exp Ther. 1972 Feb;180(2):475-83.
10
Some studies of the active intermediates formed in the microsomal metabolism of cyclophosphamide and isophosphamide.一些关于环磷酰胺和异环磷酰胺微粒体代谢过程中形成的活性中间体的研究。
Biochem Pharmacol. 1974 Jan 1;23(1):115-29. doi: 10.1016/0006-2952(74)90318-9.